Search

everythinglearnresearchcommunity

for

Search:↓

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Memory T cells in the skin balance staying put and moving into the blood, clustering around hair follicles, and increasing in number after infection.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

TRP channels in the skin are important for sensation and health, and targeting them could help treat skin disorders.

No single treatment is consistently effective for alopecia areata, and more research is needed.

The telogen phase of hair growth is active and important for preparing hair follicles for regeneration, not just a resting stage.

Abnormal ECM and immune cell interactions can cause skin diseases.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Advanced human skin models improve drug development and could replace animal testing.

Children with atopic dermatitis often have sleep problems due to itching and may benefit from melatonin, which helps with sleep and skin symptoms.

Nanoparticles can enter the skin, potentially causing toxicity, especially in damaged skin.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

People with atopic dermatitis are more likely to develop other skin conditions due to shared genetics and immune pathways.

N-WASP is essential for healthy skin and preventing inflammation.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

The document concludes that immune system abnormalities cause alopecia areata, but the exact process is still not completely understood.

The cause of alopecia areata was unknown, and while various treatments existed, no best treatment was agreed upon.

The document concludes that better understanding the wound microbiome can improve chronic wound care by preserving helpful bacteria and targeting harmful ones.

Fractional lasers and microneedling, combined with topical agents, could potentially treat Alopecia Areata effectively, but more research is needed due to limited data.

Alopecia areata involves complex immune and genetic factors, with potential treatment targets identified, but more research is needed.

The document concludes that accurate diagnosis of alopecia in children relies on thorough examination and history, and while treatments exist, none can alter the course of alopecia areata, which can significantly affect a child's psychological well-being.

The document concludes that early diagnosis and a comprehensive treatment plan are crucial for managing hair loss in children, with a focus on both medical and psychological support.

Skin and hair changes in horses can indicate serious diseases, and recognizing these signs is important for treatment and management.

The skin protects the body, regulates temperature, senses touch, and makes vitamin D.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.